Michel De Claviere

Title: Michel De Claviere: Innovator in Pharmaceutical Chemistry

Introduction

Michel De Claviere is a notable inventor based in Vilvoorde, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on decahydroquinolinol derivatives. With a total of 2 patents, his inventions focus on improving treatments for cardiovascular conditions.

Latest Patents

De Claviere's latest patents include "Novel decahydroquinolinol derivatives, and pharmaceutical compositions" and "Decahydroquinolinol derivatives and methods of treating cardiac." The first patent describes novel decahydroquinolinol derivatives represented by a specific general formula, which are useful as inhibitors of calcium translocation at the cell membrane. These compounds are particularly beneficial in treating pathological syndromes of the cardiovascular system, such as angina pectoris. The second patent also focuses on decahydroquinolinol derivatives, detailing their potential in treating cardiac conditions.

Career Highlights

Michel De Claviere is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to explore and develop innovative pharmaceutical solutions that address critical health issues.

Collaborations

De Claviere has collaborated with notable colleagues in his field, including Maurice Prost and Peter Polster. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Michel De Claviere's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the treatment of cardiovascular diseases, showcasing the importance of innovation in healthcare.